CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI GP04P

Labeling of Laboratory Prepared Materials; Proposed Guideline, GP04-P

$103.00 $207.46

CLSI NBS03-A

Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline (formerly I/LA31-A), NBS03AE

$90.00 $180.00

CLSI M07-A10 and M100-S27 Package

Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard -Tenth Edition / Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement

$128.00 $257.19

CLSI H3-A4

Procedure for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard

$136.00 $272.21